7T7-79670-34962
5 vaccinations
1 coded response
43 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 786 / TX
- Registered
- 2021-03-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
D62-24023-09370
Child or adolescent in my care · Female · 2022-06-30
Timeline
-
2021-03-08
Dose 1 — Pfizer-BioNTech
-
2021-03-15
Registered in v-safe
- 2021-03-15
- 2021-03-22
-
2021-03-29
Dose 2 — Pfizer-BioNTech
- 2021-03-29
-
2021-03-30
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-31
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-12
- 2021-04-19
- 2021-04-26
- 2021-05-03
- 2021-05-10
- 2021-06-28
-
2021-09-23
Dose 3 — Pfizer-BioNTech
- 2021-09-27
- 2022-03-29
-
2022-06-30
Dose 4 — Pfizer-BioNTech
- 2022-06-30
-
2022-07-01
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2022-07-02
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-07-03
- 2022-07-04
- 2022-07-05
- 2022-07-08
- 2022-07-17
- 2022-07-22
- 2022-07-28
- 2022-08-04
- 2022-08-11
- 2022-09-29
-
2022-10-27
Dose 5 — Moderna
-
2022-10-29
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-10-30
- 2022-11-01
- 2022-11-02
- 2022-11-06
- 2022-11-14
- 2022-11-17
- 2022-11-27
- 2022-12-03
- 2022-12-09
-
2023-01-26
Survey response — 3 months, dose 5MedDRA: COVID-19, Dizziness, Fatigue, Nasopharyngitis, Pain, Rhinorrhoea, Sneezing — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-04-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Pfizer-BioNTech | |
| 2 | 2021-03-29 | Pfizer-BioNTech | |
| 3 | 2021-09-23 | Pfizer-BioNTech | No |
| 4 | 2022-06-30 | Pfizer-BioNTech | No |
| 5 | 2022-10-27 | Moderna | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release